CompoAtlas

Féminin Sacré - Nouvelle Lune

Food supplement declared in France, declaration No 2023-8-328

Féminin Sacré - Nouvelle Lune (Ælixir Ælchimique) is a food supplement declared in France. Status: withdrawal from the market announced for 30 September 2028. Main ingredients: Artemisia vulgaris 335 mg per day, Salvia officinalis 206 mg per day, Achillea millefolium 129 mg per day, Rubus idaeus 60 mg per day, miel. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Ælixir Ælchimique
Food business operator placing the product on the market
VITURET Florent
Status
Withdrawal from the market announced for 30 September 2028
Form
Dropper
Daily dose
90 gouttes soit 834mg d'extrait
Directions for use
30 gouttes diluées dans un verre d'eau, 3 fois par jour pendant 3 semaines.
Intended populations
Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Taking anticoagulants, Taking antidepressants, Taking blood pressure medication, Taking medication, Taking thyroid medication, Prolonged use, Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Menstrual cycles, Mood

Declaration 272221, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Artemisia vulgaris L.Parties aériennesAlcoolature335 mg
Salvia officinalis L.Parties aériennesAlcoolature206 mg
Achillea millefolium L.Sommités fleuriesAlcoolature129 mg
Rubus idaeus L.Jeune pousseAutre macérât60 mg

Other active ingredients

NamePer day
mielnot declared
Eau de mernot declared

Other ingredients

Eau osmosée dynamisée, Alcool

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ce produit additionne les contre-indications de chacune des plantes qui le compose, il est donc contre-indiqué à la femme enceinte, allaitante, à l'enfant de moins de 18 ans et aux personnes aux antécédant de cancer hormonodépendant, de crises d'épilepsies ou sous traitement médicamenteux.Détail :L'Armoise commune est contre-indiquée à la femme enceinte, allaitante et à l'enfant de moins de 12 ans.La Sauge est contre-indiquée en cas d'antécédant de cancer hormonodépendant, déconseillée aux adolescents de moins de 18 ans, nécessite un avis médical en cas d'antécédant de crises d'épilepsies ou de prises d'anxiolytiques ou thymorégulateurs, nous la déconseillons à toutes personnes sous traitement médicamenteux par principe de précaution.. Son utilisation prolongée est déconseillée.L'Achillée Millefeuille nécessite un avis médical en cas de traitement anti-coagulant et attention aux allergies aux Astéracées.Le Framboisier n'ajoute aucune contre-indications supplémentaires.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Artemisia vulgaris L.
    Read the warning, when it applies and the studies cited

    MUGWORT - ARTEMISIA VULGARIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Blumenthal et al. 1998; Williamson et al. 1988).

    Sources cited by Health Canada (3)
    • Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Wichtl 2004; Hoffmann 2003).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
    • Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd edition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.

    Health Canada monograph dated 31 July 2026

  • Salvia officinalis L.
    Read the warning, when it applies and the studies cited

    SAGE - SALVIA OFFICINALIS - Buccal

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    SAGE -SALVIA OFFICINALIS Oral

    Cautions and warnings

    Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    Sources cited by Health Canada (3)
    • Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    Sources cited by Health Canada (3)
    • Bradley PR, editor. 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drug-Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Raton (FL): Taylor and Francis Group; 2013.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 10 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Ælixir Ælchimique

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Féminin Sacré - Nouvelle Lune (Ælixir Ælchimique): composition and regulation”, https://compoatlas.com/en/supplements/products/272221-feminin-sacre-nouvelle-lune, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line